CRISPR Therapeutics AG (NASDAQ:CRSP)

181.22
Delayed Data
As of Jan 25
 -7.27 / -3.86%
Today’s Change
32.30
Today|||52-Week Range
220.20
+18.36%
Year-to-Date
Where to Invest $1 Million Right Now
Jan 24 / MotleyFool.com - Paid Partner Content
Of Politics and Stock Prices
Jan 17 / MotleyFool.com - Paid Partner Content
A Deep Dive into ARK ETFs
Jan 20 / Zacks.com - Paid Partner Content
My Top Health Stock for 2021
Jan 16 / MotleyFool.com - Paid Partner Content
The Zacks Analyst Blog Highlights: CRISPR Therapeutics, Vertex Pharmaceuticals and Intellia Therapeutics
Jan 20 / Zacks.com - Paid Partner Content
7 Stocks Riding 3 Unstoppable Trends That Will Make You Richer in 2021 (and Beyond)
Jan 16 / MotleyFool.com - Paid Partner Content
Beam, SpringWorks Biggest Gainers on BioSpace List
Jan 19 / GuruFocus News - Paid Partner Content
2 Biotech Stocks That Could Double Your Money
Jan 16 / MotleyFool.com - Paid Partner Content
CRISPR (CRSP) Up More Than 80% in Past 3 Months: Here's Why
Jan 19 / Zacks.com - Paid Partner Content
5 Top-Performing ARK ETFs Worth Your Attention Now
Jan 13 / Zacks.com - Paid Partner Content
Editas (EDIT) Up More Than 100% in Past 3 Months: Here's Why
Jan 18 / Zacks.com - Paid Partner Content
Editas (EDIT) Gets FDA Nod to Begin Safety Study on EDIT-301
Jan 12 / Zacks.com - Paid Partner Content